Biotech Breakthroughs

Results

56

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

56 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	MDGL	US$565.40	9.9%	83.2%	US$12.6b	US$678.71	11.5	59.2%	n/a
	SNDX	US$24.56	17.6%	165.8%	US$2.1b	US$39.00	10.0	68.2%	n/a
	MRKR	US$1.61	11.0%	-11.0%	US$28.0m	US$7.87	7.6	69.0%	n/a
	ARDX	US$5.43	5.2%	18.0%	US$1.3b	US$16.30	3.1	55.9%	n/a
	RNXT	US$0.90	-5.8%	-31.6%	US$41.8m	US$7.03	27.3	73.0%	n/a
	FRMM	US$5.96	7.0%	-29.1%	US$75.3m	US$9.50	8.4	127.7%	n/a
	ACHV	US$6.21	-3.0%	162.0%	US$669.3m	US$13.80	59.7	64.3%	n/a
	ALDX	US$2.13	-12.3%	-52.9%	US$134.5m	US$7.17	3.0	66.9%	n/a
	LCTX	US$1.34	3.1%	26.4%	US$329.1m	US$5.50	22.6	72.3%	n/a
	CAPR	US$22.25	-3.6%	94.8%	US$1.3b	US$53.60	4.6	64.2%	n/a
	TNYA	US$0.88	18.0%	31.1%	US$199.6m	US$4.00	848.6	60.9%	n/a
	NTLA	US$16.84	-2.3%	38.8%	US$2.4b	US$26.33	35.6	67.7%	n/a
	CTOR	US$0.73	3.6%	-83.2%	US$66.0m	US$4.00	12.1	59.9%	n/a
	CGON	US$69.80	-1.5%	158.1%	US$6.1b	US$90.29	1214.1	60.1%	n/a
	VRDN	US$19.86	7.5%	16.5%	US$2.3b	US$36.13	30.9	60.9%	n/a
	LGVN	US$0.64	-11.8%	-57.1%	US$20.0m	US$7.15	16.7	55.5%	n/a
	ARQT	US$28.50	10.3%	100.4%	US$3.5b	US$34.63	8.6	48.5%	n/a
	HUMA	US$0.73	9.0%	-71.1%	US$207.9m	US$2.05	98.1	60.9%	n/a
	ACIU	US$2.52	5.9%	21.2%	US$246.5m	US$8.51	54.6	54.4%	n/a
	LRMR	US$3.61	12.5%	4.3%	US$355.9m	US$14.40	2.4	52.5%	n/a
	NAMS	US$35.83	1.9%	65.6%	US$4.3b	US$49.62	185.6	65.3%	n/a
	MNOV	US$1.40	-1.4%	10.2%	US$70.9m	US$9.00	115.5	66.7%	n/a
	INSM	US$116.53	8.9%	20.8%	US$24.5b	US$197.05	30.8	67.3%	n/a
	VERA	US$42.43	3.0%	74.3%	US$3.0b	US$81.79	6.1	63.8%	n/a

Page 1 of 2